Total Payments
$74,550
2023 Payments
$490.10
Companies
35
Transactions
140
Medicare Patients
12,757
Medicare Billing
$1.3M
Payment Breakdown by Category
Other$50,150 (67.3%)
Travel$13,628 (18.3%)
Consulting$5,750 (7.7%)
Food & Beverage$3,962 (5.3%)
Research$834.00 (1.1%)
Education$225.57 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50,150 | 17 | 67.3% |
| Travel and Lodging | $13,628 | 24 | 18.3% |
| Consulting Fee | $5,750 | 3 | 7.7% |
| Food and Beverage | $3,962 | 90 | 5.3% |
| Unspecified | $834.00 | 2 | 1.1% |
| Education | $225.57 | 4 | 0.3% |
Payments by Type
General
$73,716
138 transactions
Research
$834.00
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TESARO, Inc. | $21,386 | 21 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $20,806 | 15 | $0 (2023) |
| Celgene Corporation | $15,214 | 20 | $0 (2023) |
| Millennium Pharmaceuticals, Inc. | $12,277 | 9 | $0 (2017) |
| Varian Medical Systems, Inc. | $1,455 | 7 | $0 (2017) |
| Clovis Oncology, Inc. | $1,186 | 3 | $0 (2017) |
| Janssen Research & Development, LLC | $461.17 | 5 | $0 (2019) |
| ASD Specialty Healthcare, LLC | $168.30 | 1 | $0 (2018) |
| Daiichi Sankyo Inc. | $165.09 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $150.11 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $490.10 | 6 | Daiichi Sankyo Inc. ($165.09) |
| 2022 | $41.44 | 1 | Celgene Corporation ($41.44) |
| 2021 | $102.29 | 6 | Seagen Inc. ($40.27) |
| 2020 | $118.37 | 8 | Sirtex Medical Inc ($18.28) |
| 2019 | $14,190 | 31 | Takeda Pharmaceuticals U.S.A., Inc. ($13,408) |
| 2018 | $7,879 | 20 | Takeda Pharmaceuticals U.S.A., Inc. ($7,371) |
| 2017 | $51,729 | 68 | TESARO, Inc. ($21,386) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2023 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $114.51 | General |
| Category: Oncology | ||||||
| 12/09/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $81.91 | General |
| 05/16/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $17.04 | General |
| Category: Oncology | ||||||
| 05/10/2023 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $85.20 | General |
| 02/28/2023 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $165.09 | General |
| 02/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $26.35 | General |
| 12/10/2022 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $41.44 | General |
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 05/07/2021 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $38.42 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 04/21/2021 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Oncology | ||||||
| 04/13/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Oncology | ||||||
| 03/18/2021 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Oncology | ||||||
| 02/08/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Oncology | ||||||
| 08/19/2020 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Oncology | ||||||
| 05/19/2020 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Oncology | ||||||
| 03/06/2020 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ONCOLOGY | ||||||
| 03/05/2020 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $14.36 | General |
| 02/10/2020 | PFIZER INC. | IBRANCE (Drug), TALZENNA | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: ONCOLOGY | ||||||
| 01/27/2020 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2020 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $18.28 | General |
| Category: Interventional Oncology | ||||||
| 01/03/2020 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Oncology | ||||||
| 12/27/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 12/22/2019 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $17.59 | General |
| Category: Interventional Oncology | ||||||
| 12/13/2019 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Oncology | ||||||
| 09/19/2019 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Travel and Lodging | In-kind items and services | $954.85 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MEDI4736-MM-005 | Celgene Corporation | $834.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,930 | 9,535 | $678,301 | $236,464 |
| 2022 | 39 | 3,203 | 10,910 | $699,599 | $233,080 |
| 2021 | 49 | 3,368 | 40,326 | $1.2M | $421,253 |
| 2020 | 45 | 3,256 | 72,873 | $1.3M | $419,502 |
Total Patients
12,757
Total Services
133,644
Medicare Billing
$1.3M
Procedure Codes
166
All Medicare Procedures & Services
166 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 114 | 577 | $211,182 | $89,070 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 440 | $120,532 | $46,248 | 38.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 95 | $24,320 | $9,837 | 40.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 269 | 1,150 | $17,250 | $9,660 | 56.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 51 | 51 | $26,316 | $9,628 | 36.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 257 | 923 | $36,920 | $9,529 | 25.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 278 | 1,214 | $38,848 | $9,223 | 23.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 49 | $24,353 | $7,433 | 30.5% |
| 83735 | Magnesium level | Office | 2023 | 259 | 922 | $25,816 | $6,058 | 23.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 78 | $13,962 | $5,331 | 38.2% |
| 84100 | Phosphate level | Office | 2023 | 258 | 921 | $18,420 | $4,283 | 23.3% |
| 84550 | Uric acid level, blood | Office | 2023 | 259 | 923 | $17,537 | $4,089 | 23.3% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 59 | 400 | $15,200 | $3,645 | 24.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 92 | 221 | $12,376 | $2,926 | 23.6% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 179 | 475 | $11,875 | $2,812 | 23.7% |
| 83521 | Measurement of immunoglobulin light chains | Office | 2023 | 48 | 166 | $8,632 | $2,809 | 32.5% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 16 | 18 | $17,784 | $2,770 | 15.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 28 | 28 | $3,304 | $1,942 | 58.8% |
| 83550 | Iron binding capacity | Office | 2023 | 92 | 220 | $7,920 | $1,885 | 23.8% |
| 82232 | Beta-2 microglobulin (protein) level | Office | 2023 | 51 | 101 | $6,767 | $1,602 | 23.7% |
| 83540 | Iron level | Office | 2023 | 92 | 220 | $5,940 | $1,395 | 23.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,400 | $917.19 | 65.5% |
| 84165 | Protein measurement, serum | Office | 2023 | 47 | 87 | $3,132 | $916.11 | 29.3% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Office | 2023 | 17 | 23 | $1,725 | $503.47 | 29.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 15 | 29 | $2,001 | $477.34 | 23.9% |
About Dr. William Derosa, D.O
Dr. William Derosa, D.O is a Hematology & Oncology healthcare provider based in Morristown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902894991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Derosa, D.O has received a total of $74,550 in payments from pharmaceutical and medical device companies, with $490.10 received in 2023. These payments were reported across 140 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($50,150).
As a Medicare-enrolled provider, Derosa has provided services to 12,757 Medicare beneficiaries, totaling 133,644 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 166 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Morristown, NJ
- Active Since 10/12/2005
- Last Updated 07/21/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1902894991
Products in Payments
- NINLARO (Drug) $33,056
- ZEJULA (Drug) $21,270
- Revlimid (Drug) $6,579
- Abraxane (Drug) $4,675
- Rubraca (Drug) $1,186
- Durvalumab (Drug) $834.00
- DARZALEX (Drug) $461.17
- VARUBI (Drug) $116.00
- Imbruvica (Drug) $114.92
- Epkinly (Drug) $114.51
- ARN-509 (Biological) $110.19
- Venclexta (Drug) $98.89
- SIR-Spheres Microspheres (Device) $94.50
- KEYTRUDA (Biological) $64.96
- KISQALI (Drug) $49.36
- ADCETRIS (Biological) $43.61
- LYNPARZA (Drug) $41.90
- Nerlynx (Drug) $41.57
- myRisk (Device) $38.42
- Lenvima (Drug) $29.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Morristown
Charles Farber, M.d, Phd, M.D, PHD
Hematology & Oncology — Payments: $740,251
Hematology & Oncology $740,251
Michael Scola, M.d, M.D
Hematology & Oncology — Payments: $692,337
Hematology & Oncology $692,337
Mohamad Cherry, Md, MD
Hematology & Oncology — Payments: $224,737
Hematology & Oncology $224,737
Steven Papish, M.d, M.D
Hematology & Oncology — Payments: $58,615
Hematology & Oncology $58,615
Dr. Muhammad Naqvi, M.d, M.D
Hematology & Oncology — Payments: $35,581
Hematology & Oncology $35,581
Dr. Clarissa Geyer, M.d, M.D
Hematology & Oncology — Payments: $9,556
Hematology & Oncology $9,556